Schedule 13G ownership disclosure

UNUM THERAPEUTICS INC

Security class unavailable · CUSIP: 903214104

Event date: 2020-07-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-084846
Form type
SC 13G
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Jul 20, 2020
Reporting period
Jul 09, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub